|
Merck Serono announces five-year strategic partnership with the Lead Discovery Center
|
13 November 2013 |
|
Merck announces collaboration with nordic Bioscience for Sprifermin
|
18 March 2013 |
|
Merck total revenues increase 3.2% to € 2.6 billion
|
17 May 2012 |
|
Merck announces efficiency program across all businesses and regions
|
26 February 2012 |
|
Merck Helps Eliminate Schistosomiasis in Africa
|
13 December 2011 |
|
Merck Sends Assistance to Flood-Ravaged Thailand
|
23 November 2011 |
|
Merck Total Revenues Increase by 4% to € 2.5 Billion
|
26 October 2011 |
|
Merck and Ono Pharmaceutical Form Collaborations
|
05 October 2011 |
|
Merck publishes innovation brochure with interactive features
|
28 September 2011 |
|
Merck Total Revenues Increase by 16% to EUR 2.6 Billion
|
27 July 2011 |
|
Merck: Regulatory Update on Cladribine Tablets
|
24 June 2011 |
|
Merck and Its Employees to Donate to Japanese Relief Effort
|
29 March 2011 |
|
Merck KGaA Acquires Supplier to Biopharma Industry in China
|
05 January 2011 |
|
Merck KGaA and sanofi-aventis to Investigate Novel Combinations Against Cancer
|
19 December 2010 |
|
Merck KGaA Donation Program Supports Schistosomiasis Control in Africa
|
08 December 2010 |
|
Merck KGaA Announces Extension of FDA Priority Review Period for Cladribine Tablets
|
26 November 2010 |
|
Merck KGaA Sells Théramex To Teva for EUR 265 million
|
29 October 2010 |
|
Merck KGaA Profit After Tax Jumps 45% to EUR 215 Million
|
27 October 2010 |
|
Merck KGaA to Introduce RebiDose, the Rebif Single Use Pre-filled Pen for Treatment of Multiple Sclerosis
|
16 October 2010 |
|
Merck KGaA Announces CHMP Opinion for Cladribine Tablets in Multiple Sclerosis
|
24 September 2010 |